Drug Store News5d
FDA approves new indication for Novo Nordisk’s Ozempic
Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 ...
Je suis passé du 5XL à la taille M en un an, sans médicaments mais avec ce simple changement
Un Britannique de 31 ans, a réussi à transformer sa vie en perdant 58 kg en un an. Sans recourir à des médicaments, il a ...
India TV13d
US FDA approves Novo Nordisk's Ozempic to reduce risk of kidney diseases in diabetic patients
The US Food and Drug Administration (FDA) has approved Novo Nordisk's Ozempic to lower the risk of kidney failure and disease progression. According to a statement made by the Danish ...
London Evening Standard14d
7 easy ways to lose weight (without taking Ozempic)
She adds that weight loss injections such as Ozempic can lead to muscle wastage (as with any crash diet), “which is detrimental to us, especially as we age”, and also can lead to weight regain ...
Le Journal de Québec14d
Ozempic sous surveillance: le médicament peut-il améliorer les performances sportives?
L’Ozempic, connu comme étant un produit pour les diabétiques et popularisé par les personnes qui veulent perdre du poids, est désormais surveillé par l’Agence mondiale d’antidopage (AMA).
Investing14d
FDA approves Ozempic for kidney disease treatment in diabetes patients
Investing.com -- The U.S. Food and Drug Administration (FDA) has granted approval for an expanded use of Ozempic® (semaglutide) injection, developed by pharmaceutical company Novo Nordisk (NYSE:NVO).